70938-42-0

Basic information

• Product Name: 1H-BENZO[D][1,2,3]TRIAZOLE-5-CARBALDEHYDE
• Synonyms: 1H-BENZO[D][1,2,3]TRIAZOLE-5-CARBALDEHYDE;1H-Benzotriazole-5-carboxaldehyde (9CI);1H-Benzotriazole-5-carboxaldehyde
• CAS NO: 70938-42-0
• Molecular Formula: C₇H₅N₃O
• Molecular Weight: 147.1341
• Product Categories: ALDEHYDE
• Mol File: 70938-42-0.mol
• Article Data: 7

Chemical Properties

• Boiling Point: 448.9±18.0 °C(Predicted)
• Appearance: /
• Density: 1.471±0.06 g/cm3(Predicted)
• PKA: 7.51±0.40(Predicted)
• CAS DataBase Reference: 1H-BENZO[D][1,2,3]TRIAZOLE-5-CARBALDEHYDE(CAS DataBase Reference)
• NIST Chemistry Reference: 1H-BENZO[D][1,2,3]TRIAZOLE-5-CARBALDEHYDE(70938-42-0)
• EPA Substance Registry System: 1H-BENZO[D][1,2,3]TRIAZOLE-5-CARBALDEHYDE(70938-42-0)

Safety Data

• Hazardous Substances Data: 70938-42-0(Hazardous Substances Data)

Usage

General Description

1H-Benzo[d][1,2,3]triazole-5-carbaldehyde is a chemical compound with the molecular formula C8H6N4O. It is a fused heterocyclic compound with a benzene ring fused to a triazole ring, and an aldehyde group attached at the 5-position of the triazole ring. This chemical is an important building block in the synthesis of various pharmaceuticals, agrochemicals, and advanced materials. It is also used as a precursor in the preparation of fluorescent compounds and metal-organic frameworks. 1H-Benzo[d][1,2,3]triazole-5-carbaldehyde has potential applications in various fields due to its unique structure and versatile reactivity.

Upstream product

• 106429-67-8 (1H-benzo[d][1,2,3]triazol-5-yl)methanol 
• 23814-12-2 1h-benzotriazole-5-carboxylic acid 
• 113053-50-2 1H-Benzotriazole-5-carboxylic acid methyl ester 
• 491612-10-3 C₈H₇N₃O₂ 
• 1246639-99-5 C₁₀H₁₁N₃O₂ 
• 68-12-2 N,N-dimethyl-formamide 

Downstream Products

• 1168721-90-1 (E)-3-((1H-indazol-6-yl)methylene)-5-methoxyindolin-2-one 
• 1402728-95-3 (1E,6E)-1-(1H-benzotriazol-5-yl)-7-[2-methoxy-4-(2-pyridylmethoxy)phenyl]hepta-1,6-diene-3,5-dione 

Relevant articles and documents

NOVEL HETEROCYCLIC DERIVATIVES WITH CARDIOMYOCYTE PROLIFERATION ACTIVITY FOR TREATMENT OF HEART DISEASES

Provided are novel heterocyclic derivatives with cardiomyocyte proliferation activity for treatment of heart diseases. Specifically, provided are the compounds of formula (I) or pharmaceutically acceptable salts, stereoisomers, solvates or prodrugs, prepa

NOVEL CURCUMIN DERIVATIVE

The present invention provides a novel compound that is structurally similar to curcumin and has a suppressive effect on Aβ aggregation, a degradative effect on Aβ aggregates, an inhibitory effect on β-secretase, and a protective effect on neurons. The novel compound is a compound represented by the following general formula (Ia) or a salt thereof: wherein R1 represents a 4-hydroxy-3-methoxyphenyl group or the like, and R2 represents a 1H-indol-6-yl group or the like.

Novel potent antagonists of transient receptor potential channel, vanilloid subfamily member 1: Structure-activity relationship of 1,3-diarylalkyl thioureas possessing new vanilloid equivalents

Recently, 1,3-diarylalkyl thioureas have merged as one of the promising nonvanilloid TRPV1 antagonists possessing excellent therapeutic potential in pain regulation. In this paper, the full structure-activity relationship for TRPV1 antagonism of a novel series of 1,3-diarylalky thioureas is reported. Exploration of the structure-activity relationship, by systemically modulating three essential pharmacophoric regions, led to six examples of 1,3-dibenzyl thioureas, which exhibit Ca2+ uptake inhibition in rat DRG neuron with IC50 between 10 and 100 nM.